AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PHD wins pounds 6m Bayer and Roche media.(Bayer Pharma S.A. and Roche Holding Ltd.'s ad account)(Brief Article)
PHD has defeated MediaCom to win the pounds 6 million UK centralised media account for the pharmaceutical companies Bayer and Roche.
The account was put up for review following Bayer's purchase of the over-the-counter division of Roche. PHD was the incumbent on the former and MediaCom on the latter.
The dollars 2.9 billion purchase of Roche's OTC division has made Bayer one of the biggest consumer health organisations in the world. Its brands include Alka-Seltzer, Rennie and Berocca.
Bayer and Roche's creative accounts, held by Abbott Mead Vickers BBDO and JWT, were unaffected.
Separately, PHD has also won the pounds 33 million media planning account for the AA after a head-to-head battle against MindShare. The ...
- Arthur L. Caplan, PhD Will Keynote Defined Health's Therapeutic Insight 2005...
- Press release article from: PR Newswire February 17, 2005 700+ words
...Director, Warburg Pincus Jeremy Levin, PhD, Global Head, Strategic Alliances, Novartis...President & CEO, Affymax Paul Nakagaki, PhD, Head of Pharma Research Strategy, Roche Aileen Nicoletti, PhD, Senior Consultant, Defined Health Elizabeth...
- Roche Molecular Systems, Inc. Names Three Vice Presidents.
- Press release article from: Business Wire June 21, 1999 700+ words
...Martin D. Madaus, PhD, is the new vice...In mid-1997, Roche entered the blood...general manager of Roche Diagnostics-Canada. He earned his PhD in veterinary medicine...Joanne P. Spadoro, PhD, has been named vice...operations. Spadoro joined Roche Molecular Systems...
- Roche Molecular Systems Initiates U.S. Clinical Trials Of COBAS AmpliScreen(TM)...
- Press release article from: PR Newswire August 22, 2002 700+ words
...noted D. Michael Strong, PhD, executive vice president...involved in the trial. "The Roche test has demonstrated...added Dr. Holland. Roche is able to move forward...said Heiner Dreismann, PhD, head of Roche Molecular Diagnostics...
- Heiner Dreismann, PhD, Laurence R. McCarthy, PhD, and Stuart A. Auerbach Join...
- Press release article from: PR Newswire August 30, 2007 700+ words
...directors have joined its board: Heiner Dreismann, PhD, former president and CEO of Roche Molecular Diagnostics (RMD), a pioneer in PCR...Hoffmann-La Roche Ltd.; Laurence R. McCarthy, PhD, former president and CEO of Focus Diagnostics...
- Roche Accelerates Effort to Develop PCR Blood Screening Assay for West Nile...
- Press release article from: PR Newswire October 29, 2002 700+ words
...the public health labs has used Roche's PCR technology," said Richard...Vice President, Blood Screening, Roche Molecular Diagnostics. "The ground...involved," said Heiner Dreismann, PhD, head of Roche Molecular Diagnostics. "We will...
- Roche accelerates effort to develop blood screening assay.
- Newspaper article from: Blood Weekly December 5, 2002 700+ words
...the public health labs has used Roche's PCR technology," said Richard...vice president, blood screening, Roche Molecular Diagnostics. "The ground...involved," said Heiner Dreismann, PhD, head of Roche Molecular Diagnostics. "We will...
- Dr Rose Roche inspecting a cotton trial; Narrow rows widen chance of higher...
- Press release article from: M2 Presswire May 8, 2007 700+ words
...2007-CSIRO AUSTRALIA: Dr Rose Roche inspecting a cotton trial; Narrow...research - completed by Rose Roche at Narrabri as part of her PhD with The University of Queensland...all pin down the facts," Ms Roche says. "Across all our experiments...
- Arthur L. Caplan, PhD Will Keynote Defined Health's Therapeutic Insight 2006.
- Press release article from: PR Newswire December 20, 2005 700+ words
...Cellerant Therapeutics David DeMarco, PhD, Vice President, Strategic Planning...Medicines Company Paul C. Nakagaki, PhD, Head, Pharma Research Strategy...Pharmaceuticals Division, F. Hoffmann-La Roche Ltd. Roger S. Newton, PhD, Sr. VP, PGRD, Director, Esperion...